• About
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, April 11, 2021
amarhealth.com
Advertisement
  • Home
  • Kids Corner
  • Country wide health
  • Pharmaceuticals
  • Amar Doctor
  • Celebrity Health
  • Health Tips
  • More
    • Good News
    • Spot Light
    • Health Crime
    • Write up
    • Environment health
    • Health Institute
Bangla Site
  • Home
  • Kids Corner
  • Country wide health
  • Pharmaceuticals
  • Amar Doctor
  • Celebrity Health
  • Health Tips
  • More
    • Good News
    • Spot Light
    • Health Crime
    • Write up
    • Environment health
    • Health Institute
Bangla Site
amarhealth.com

 Bangla Site 

Home Breaking news

AstraZeneca serves legal notice on SII over vaccine supply delays

April 8, 2021
in Breaking news, Health Institute, Pharmaceuticals
AstraZeneca serves legal notice on SII over vaccine supply delays
2.5k
VIEWS
Share on FacebookShare on LinkedinShare on Twitter

Health Desk – 08 Apr, 2021: AstraZeneca has sent a legal notice to the Serum Institute of India over vaccine supply delays, Indian media outlets report.
“AstraZeneca has sent us a legal notice (for delays in supplying the vaccine) and the Indian government is also aware of that. I cannot comment on the legal notice as it is confidential, but we are examining all avenues to amicably manage and resolve legal disputes over contractual obligations that Serum Institute is not able to fulfil due to its prioritisation of Indian supplies,” CEO Adar Poonawalla of SII said in an interview with India’s Business Standard.

“Everyone has been very understanding so far. The government is evaluating what it can do to resolve the issue.”

Poonawalla had told NDTV that Serum’s production capacity to manufacture Covishield — one of the two vaccines being administered in India — is “very stressed, to put it frankly”, amid pressure from soaring cases in the country.

He also said the government’s pause on major Covishield shipments to other countries and the “first claim” deal with India were difficult to explain abroad, where the vaccine was sold at a substantially higher cost per dose.

The world “needs this vaccine and we are prioritising the needs of India at the moment and we are still short of being able to supply… to every Indian that needs it”, Poonawalla said in the interview.

Poonawalla said SII, which produces between 60 million and 65 million doses per month, has so far delivered around 100 million doses to the centre and exported 60 million.

SII needed Rs 3,000 crore to ramp up capacity needed to scale up production by June, he said.

Serum produces over two million doses of Covishield — the name in India for the AstraZeneca vaccine — a day. It is providing the shot at a subsidised rate of around Rs 150 to the government, significantly less than what it charges for exports.

“We’re supplying in India at approximately Rs 150-160. The average price is around ₹ 1,500… (but) because of the Modi government’s request, we are providing at subsidised rates… It is not that we’re not making profits… but we are not making super-profits, which is key to re-investing,” he said.

“This (the amount needed) would be roughly Rs 3,000 crores. The process takes 85 days, so it would be just under three months before we scale up operations,” he said, adding that he had written to the government, failing which Serum Institute would approach banks for a loan.

“This was never budgeted or planned initially because we were supposed to export and get the funding from export countries but now that that is not happening, we have to find other innovative ways to build our capacity.”

Poonawalla said even if SII could increase its capacity to around 100 million doses per month, India needed other manufacturers to scale up in order to meet requirements.

Previous Post

South African variant of Covid-19 dominant in Dhaka: icddr,b study

Next Post

Indian PM NarendraModi gets second dose of Covid vaccine

Next Post
Indian PM NarendraModi gets second dose of Covid vaccine

Indian PM NarendraModi gets second dose of Covid vaccine

New Zealand suspends entry for travellers from India due to high Covid-19 cases

New Zealand suspends entry for travellers from India due to high Covid-19 cases

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected test

  • 85 Followers
  • 113k Subscribers
  • 23k Followers
  • 99 Subscribers
  • Trending
  • Comments
  • Latest
Health Minister receives Covid-19 Vaccine

Health Minister receives Covid-19 Vaccine

February 7, 2021
More countries act against exposure to radon and associated cancer risks

More countries act against exposure to radon and associated cancer risks

February 5, 2021
WHO issues new guidelines on the management of chronic pain in children

WHO issues new guidelines on the management of chronic pain in children

January 28, 2021
MotoGP makes tyre strategies easier to follow for 2017

MotoGP makes tyre strategies easier to follow for 2017

January 11, 2021
India reports record 152,879 new COVID-19 infections

India reports record 152,879 new COVID-19 infections

0
WHO, Sanofi renew collaboration to sustain elimination efforts

WHO, Sanofi renew collaboration to sustain elimination efforts

0
Oxford/AstraZeneca Covid vaccine ‘dose error’ explained

Oxford/AstraZeneca Covid vaccine ‘dose error’ explained

0
Hackers steal vaccine data in Europe, companies say

Hackers steal vaccine data in Europe, companies say

0
India reports record 152,879 new COVID-19 infections

India reports record 152,879 new COVID-19 infections

April 11, 2021
South African Covid-19 variant can ‘break through’ Pfizer vaccine: study

South African Covid-19 variant can ‘break through’ Pfizer vaccine: study

April 11, 2021
CAAB mulls suspension of international flights from Dhaka amid strict lockdown

CAAB mulls suspension of international flights from Dhaka amid strict lockdown

April 11, 2021
Ongoing restrictions to continue on April 12, 13: Quader

Ongoing restrictions to continue on April 12, 13: Quader

April 11, 2021

Recent News

India reports record 152,879 new COVID-19 infections

India reports record 152,879 new COVID-19 infections

April 11, 2021
South African Covid-19 variant can ‘break through’ Pfizer vaccine: study

South African Covid-19 variant can ‘break through’ Pfizer vaccine: study

April 11, 2021
CAAB mulls suspension of international flights from Dhaka amid strict lockdown

CAAB mulls suspension of international flights from Dhaka amid strict lockdown

April 11, 2021
Ongoing restrictions to continue on April 12, 13: Quader

Ongoing restrictions to continue on April 12, 13: Quader

April 11, 2021
amarhealth.com

Editor: Dr Apurba Pandit

Executve Editor: Mahfuzur Rahman


Office: 65 Mymensingh Lane (6th Floor), Banglamotor, Dhaka.
Phone: 01711345029
Email: newsamarhealth@gmail.com

Follow Us

Browse by Category

  • Amar Doctor
  • Breaking news
  • Celebrity Health
  • Country wide health
  • Environment health
  • Good News
  • Health Crime
  • Health Institute
  • Health Tips
  • Kids Corner
  • Pharmaceuticals
  • Spot Light
  • Uncategorized
  • Write up

Registration of online portal

Recent News

India reports record 152,879 new COVID-19 infections

India reports record 152,879 new COVID-19 infections

April 11, 2021
South African Covid-19 variant can ‘break through’ Pfizer vaccine: study

South African Covid-19 variant can ‘break through’ Pfizer vaccine: study

April 11, 2021
  • About
  • Advertise
  • Privacy & Policy
  • Contact

Copyright © 2016. All rights reserved amarhealth.Com

No Result
View All Result
  • Kids Corner
  • Good News
  • Health Crime
  • Health Tips
  • Pharmaceuticals
  • Celebrity Health
  • Spot Light
  • Health Institute
  • Amar Doctor
  • Environment health
  • Country wide health
  • Write up

Copyright © 2016. All rights reserved amarhealth.Com